EP0467031A3
Medical-grade lipid-coated microbubbles, paramagnetic labelling thereof and their therapeutic use
Abstract
This invention relates to a large scale method for the production of medical grade lipid-coated microbubbles, to the paramagnetic labeling of such microbubbles and to therapeutic applications for the microbubbles. More particularly, the invention relates to a method of the production of medical grade, concentrated suspensions of stable, paramagnetically derivatized or underivatized microbubbles useful for ultrasonic and magnetic resonance imaging and also relates to therapeutic interventions such as selective tumor destruction.

Term
Term ended
Projected expiry passed 13 May 2011, 15.4 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both ways
| Document | Relation | Office | Category | Cited during |
|---|---|---|---|---|
| EP0160552A2 | Cites | European Patent Office (EPO) | X | Search report |
| EP0272091A2 | Cites | European Patent Office (EPO) | X | Search report |
| US4684479A | Cites | United States of America | XD | Search report |
| US4900540A | Cites | United States of America | X | Search report |
| WO8905160A1 | Cites | World Intellectual Property Organization (WIPO) | X | Search report |
| INVESTIGATIVE RADIOLOGY, vol. 25, December 1990, pages 1300-1304, Philadelphia, PA, US; R.H. SIMON et al.: "Lipid-coated ultrastable microbubbles as a contrast agent in neurosonography" | Non-patent | – | – | Search report |
| MAGNETIC RESONANCE IN MEDICINE, vol. 3, 1986, pages 541-548, Academic Press, Inc., New York, US; R.B. LAUFFER et al.: "1/T1 NMRD profiles of solutions of Mn2+ and Gd3+ protein-chelate conjugates" | Non-patent | – | – | Search report |
10 members in 5 offices; this record represents the family
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 550620 | United States of America | – | |
| 55062090 | United States of America | A |
Members10
| Document | Office | Kind | |
|---|---|---|---|
| AU8029791A | Australia | A | |
| EP0467031A2 | European Patent Office (EPO) | A2 | |
| EP0467031A3This record | European Patent Office (EPO) | A3 | |
| US5215680A | United States of America | A | |
| AU657480B2 | Australia | B2 | |
| EP0467031B1 | European Patent Office (EPO) | B1 | |
| AT156020T | Austria | T | |
| ATE156020T1 | Austria | T1 | |
| DE69127032D1 | Germany | D1 | |
| DE69127032T2 | Germany | T2 |
42 legal events, as 4 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Expiry of rightR071 | R071 | DE | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| Correction of patent specification (complete document) publishedK2C3 | K2C3 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents actLapsedNLV1 | NLV1 | EP | |
| Fr: translation filedET | ET | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Corresponds to:REF | REF | EP | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0467031
- Application
- 911076925
Titles3
- German
- Lipid-beschichtete Mikrobläschen, ihre paramagnetische Markierung und ihre therapeutische Anwendung
- English
- Medical-grade lipid-coated microbubbles, paramagnetic labelling thereof and their therapeutic use
- French
- Microbulles à enrobage lipidique, leur marquage paramagnétique, et application thérapeutique
Classification
- CPC, 6
- A61K9/5015
- A61K41/0047
- A61K49/18
- A61K49/1815
- A61K49/223
- Y10T436/24
- IPC, 4
- A61K9 50
- A61K41 00
- A61K49 18
- A61K49 22
Designated states14
- Contracting states, 14
- Austria
- Belgium
- Switzerland
- Germany
- Denmark
- Spain
- France
- United Kingdom
- Greece
- Italy
- Liechtenstein
- Luxembourg
- Netherlands (Kingdom of the)
- Sweden